Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Cat study provides insight into dementia progress
The latest findings also reinforce the benefit of cat owners recognising signs of disease.
The study found parallels in the development of cognitive disease in both cats and humans. 

The University of Edinburgh Royal (Dick) School of Veterinary Studies, alongside the University of California, has found that key proteins linked to cognitive disease are found in similar ways in both cats and humans.
 
This new research demonstrates that the development of feline cognitive dysfunction syndrome (CDS) functions similarly to dementia in several ways. 

It is hoped that these findings will support fast diagnosis and treatment of cognitive disease in cats and humans, as they assist in understanding the indicators of the disease. 

In the study, researchers aimed to understand how beta-amyloid and tau, two key proteins, develop in cats of all ages, and how they relate to the development of CDS. 

The research ultimately found that the accumulation of tau proteins, and the region in the brain in which this occurs, are key indicators of the progress of dementia in cats, and that the clinical signs developed in feline CDS are similar to that of human Alzheimers disease. 

Published in Frontiers in Aging, the study is available to read here

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
Lords Committee opens Pet Parasite Medication inquiry

The House of Lords Environment and Climate Change Committee will launch its inquiry into Pet Parasite Medication (PPM) on Wednesday (3 June).

Focusing on treatments containing fipronil and imidacloprid, the inquiry will seek to understand distribution pathways and the impacts of PPM use and non-use on biodiversity and human health. It will also cover current regulation, monitoring, and the potential implications for pets and their owners.

The committee will hear evidence from environmental non-governmental organisations and research institutes. The public can follow the proceedings live on Parliament TV or in person in the Palace of Westminster.